Why this matters to buyers
Buyers of Johnson & Johnson products, particularly in the innovative medicine segment, may experience potential changes in supply chain operations, facility locations, or product availability as the restructuring proceeds.
Recommended buyer actions
- Monitor announcements from Johnson & Johnson regarding supply chain changes
- Assess potential risks to current supply agreements or product availability
Original source context
The project, which is largely tied to the innovative medicine segment, will see the company exit certain facilities and incur costs of up to $750 million.
Read the original report · Supply Chain Dive